1. Home
  2. SNTI vs HUSA Comparison

SNTI vs HUSA Comparison

Compare SNTI & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • HUSA
  • Stock Information
  • Founded
  • SNTI 2016
  • HUSA N/A
  • Country
  • SNTI United States
  • HUSA United States
  • Employees
  • SNTI N/A
  • HUSA N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • HUSA Oil & Gas Production
  • Sector
  • SNTI Health Care
  • HUSA Energy
  • Exchange
  • SNTI Nasdaq
  • HUSA Nasdaq
  • Market Cap
  • SNTI 14.1M
  • HUSA 13.1M
  • IPO Year
  • SNTI N/A
  • HUSA N/A
  • Fundamental
  • Price
  • SNTI $2.18
  • HUSA $1.49
  • Analyst Decision
  • SNTI
  • HUSA
  • Analyst Count
  • SNTI 0
  • HUSA 0
  • Target Price
  • SNTI N/A
  • HUSA N/A
  • AVG Volume (30 Days)
  • SNTI 19.2K
  • HUSA 1.1M
  • Earning Date
  • SNTI 11-11-2024
  • HUSA 11-12-2024
  • Dividend Yield
  • SNTI N/A
  • HUSA N/A
  • EPS Growth
  • SNTI N/A
  • HUSA N/A
  • EPS
  • SNTI N/A
  • HUSA N/A
  • Revenue
  • SNTI $338,000.00
  • HUSA $623,103.00
  • Revenue This Year
  • SNTI $254.47
  • HUSA N/A
  • Revenue Next Year
  • SNTI $169.66
  • HUSA N/A
  • P/E Ratio
  • SNTI N/A
  • HUSA N/A
  • Revenue Growth
  • SNTI N/A
  • HUSA N/A
  • 52 Week Low
  • SNTI $1.52
  • HUSA $0.96
  • 52 Week High
  • SNTI $8.48
  • HUSA $2.81
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 34.39
  • HUSA 72.08
  • Support Level
  • SNTI $2.08
  • HUSA $1.05
  • Resistance Level
  • SNTI $2.46
  • HUSA $1.55
  • Average True Range (ATR)
  • SNTI 0.25
  • HUSA 0.12
  • MACD
  • SNTI -0.11
  • HUSA 0.05
  • Stochastic Oscillator
  • SNTI 10.48
  • HUSA 80.02

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

Share on Social Networks: